Back to overview

Review on Adenosine in the treatment of neuropathic pain published in the Scandinavian Journal of Pain

December 15, 2023

Henrik Klitgaard (Co-Founder, PhD) and Stine Norman-Hansen (Senior Scientist, PhD) authored this topical review together with leading pain expert, Prof. Lars Arendt-Nielsen.

Read the full article here.

Publication
30.9.2026
Neumirna presents preclinical Parkinson's disease data at AD/PD
Data presented at AD/PD show that targeting miR-27b may influence several interconnected biological processes implicated in Parkinson's disease.
Read full article
Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article
Back to overview

Review on Adenosine in the treatment of neuropathic pain published in the Scandinavian Journal of Pain

December 15, 2023

Henrik Klitgaard (Co-Founder, PhD) and Stine Norman-Hansen (Senior Scientist, PhD) authored this topical review together with leading pain expert, Prof. Lars Arendt-Nielsen.

Read the full article here.

Publication
30.9.2026
Neumirna presents preclinical Parkinson's disease data at AD/PD
Data presented at AD/PD show that targeting miR-27b may influence several interconnected biological processes implicated in Parkinson's disease.
Read full article
Funding
Publication
27.3.2026
Meet Neumirna at Conferences and Events in 2026
Find out where you can connect with our team this year
Read full article
Development
Publication
12.1.2026
Neumirna at AES: new data on NMT.001
At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.
Read full article